BREAKING NEWS Officer-involved shooting at Verona Convenience Store Full Story
WEATHER AUTHORITY : Dense Fog Advisory View Alerts

Many women with common breast cancer can safely skip chemo, study says

About 70% of women diagnosed with the early stages of one of the most common forms of breast cancer might not need ch...

Posted: Jun 4, 2018 10:26 AM
Updated: Jun 4, 2018 10:26 AM

About 70% of women diagnosed with the early stages of one of the most common forms of breast cancer might not need chemotherapy as part of treatment, according to the results of a long-awaited study presented at the American Society of Clinical Oncology meeting in Chicago Sunday.

The study, published Sunday in the New England Journal of Medicine, analyzed how well a widely used genetic test assessed cancer risk, based on 21 genes linked with breast cancer recurrence.

70% of women with common form of breast cancer might need only hormone therapy

Genetic test can assess breast cancer to personalize treatment

"These data confirm that using a 21-gene expression test to assess the risk of cancer recurrence can spare women unnecessary treatment if the test indicates that chemotherapy is not likely to provide benefit," lead author Dr. Joseph A. Sparano, associate director for clinical research at the Albert Einstein Cancer Center, said in a statement. The study was sponsored by the National Cancer Institute and led by the ECOG-ACRIN Cancer Research Group.

"I'm delighted," said Dr. Otis Brawley, chief medical and scientific officer for the American Cancer Society, who was not part of the study. "I've been worried for a long time about unnecessary treatment for cancer, and unnecessary side effects from chemotherapy.

"Now with these genomic tests, we are finding that we have multiple types of breast cancer, perhaps several dozen," said Brawley, "and we are being able to tailor our therapies to the type of breast cancer every woman has."

Breast cancer is the most common cancer in women worldwide; the World Cancer Research Fund International reported 1.7 million new cases in 2012. About 50% of all women diagnosed worldwide have hormone-receptor positive, HER2-negative, node-negative cancer. Treatment options include estrogen-blocking drugs along with doses of chemotherapy to lower the risk of recurrence.

Women affected by the new findings are estrogen-sensitive, test negative for HER2 and have early stage tumors below five centimeters that have not spread to lymph nodes. They also have a score between 11 and 25 on the Oncotype DX Breast Recurrence Score test.

"What that test does is look at 21 different genes to see if each is turned on or off and then if it is over-expressed or not," Brawley said. "So we have two yes-no answers for each gene. It looks at all 21 of those answers and gives that cancer a recurrent score between 0 and 100."

Past research has shown that women with scores between 0 and 10 could skip chemotherapy, while those with scores over 25 benefited from adding chemotherapy to their hormonal treatment plan.

"Those are the cancers that have likely already metastasized and a small amount could be hiding in a woman's lung, liver or bones," said Brawley. "Therefore they should get the chemotherapy along with hormonal treatment."

But doctors have been unsure how to treat women with scores in the intermediate range of 11 and 25. Protectively, many of those women have received chemotherapy, which can have devastating side effects, including anemia, a weakened immune system, hair loss, diarrhea, fatigue and memory loss.

Other less common but more serious side effects of chemotherapy include bone loss and osteoporosis, heart and vision problems.

The phase III clinical trial, named "TAILORx," followed over 10,000 women diagnosed with breast cancer between 2006 and 2010. Of those women, 6,711 had test scores between 11 and 25, which placed them in the intermediate risk group. Those women were then randomized into two trials: one received hormone therapy with chemotherapy; the other received hormone therapy alone.

Researchers followed the women for an average of nine years. At the end of that time they found 83.3% of those on hormone therapy alone had not developed a recurrence or a second primary cancer. For the group that had both hormone and chemotherapy, the rate was 84.3%, a difference that was not statistically significant.

The overall survival rate was similar: 93.9% for those who received hormone therapy alone and 93.8% for those who received both therapies.

"These findings, showing no benefit from receiving chemotherapy plus hormone therapy for most patients in this intermediate-risk group, will go a long way to support oncologists and patients in decisions about the best course of treatment," Dr. Jeffrey Abrams, associate director of the National Cancer Institute's Cancer Therapy Evaluation Program, said in a statement.

Thirty percent of the women in the trial did have evidence of cancer hiding in their bodies. For these women, the use of both hormones and chemotherapy is recommended.

"We'll give women in this group about six months of chemotherapy," Brawley said.

But there is a note of caution in interpreting the study's findings. Data on premenopausal women and those younger than 50 who scored at the higher end of the intermediate-risk range,16 to 25, was analyzed separately. The results showed there might be a small benefit from chemotherapy.

"Tumors grow more aggressively in premenopausal women, not just women under 50," Brawley said.

Those women should carefully discuss their options with their oncologist, said Brawley, because they would likely be candidates for the more aggressive, dual therapies.

If the woman's score is 16 or higher and she is premenopausal, "then we're going to want to give her the chemotherapy," said Brawley.

In a media release, Genomic Health, who makes the Oncotype DX Breast Recurrence Score test, said it provided funding for collection of follow-up information from the treating sites, but was not involved in the planning and execution of the study.

Mississippi Coronavirus Cases

Data is updated nightly.

Cases: 263023

Reported Deaths: 5752
CountyCasesDeaths
DeSoto17675191
Hinds16813331
Harrison14224204
Rankin11167219
Jackson10839190
Lee9050144
Madison8568168
Jones6668114
Forrest6177124
Lauderdale6097192
Lowndes5518120
Lafayette516298
Lamar503965
Washington4923125
Bolivar4104109
Oktibbeha405982
Panola384881
Pontotoc376258
Warren3674103
Monroe3671108
Union355663
Marshall355270
Neshoba3485154
Pearl River3468105
Leflore3111109
Lincoln305688
Hancock291862
Sunflower291475
Tate279662
Alcorn272354
Pike268981
Itawamba268063
Scott259648
Yazoo255256
Prentiss252553
Tippah249250
Copiah249049
Coahoma248054
Simpson242171
Leake237367
Grenada223272
Marion222073
Covington219973
Adams213671
Wayne212634
Winston207371
George204339
Newton199046
Attala196963
Tishomingo194161
Chickasaw189044
Jasper179538
Holmes171768
Clay165837
Tallahatchie156235
Stone151425
Clarke147262
Calhoun140822
Smith129226
Yalobusha122034
Walthall114337
Greene113529
Noxubee112926
Montgomery111636
Carroll106622
Lawrence106517
Perry104531
Amite101426
Webster96124
Tunica88821
Claiborne88325
Jefferson Davis88329
Benton85623
Humphreys84624
Kemper80520
Quitman7089
Franklin69917
Choctaw63213
Wilkinson59825
Jefferson56821
Sharkey45117
Issaquena1606
Unassigned00

Alabama Coronavirus Cases

Cases: 439442

Reported Deaths: 6657
CountyCasesDeaths
Jefferson644371007
Mobile31435569
Madison28158217
Tuscaloosa21492275
Montgomery19873332
Shelby19248132
Baldwin17128189
Lee13137107
Morgan12594142
Etowah12070181
Calhoun11496206
Marshall10420123
Houston8988164
Limestone832081
Cullman8257124
Elmore8183110
DeKalb7871107
Lauderdale7847107
St. Clair7808130
Talladega6445112
Walker6028183
Jackson599145
Colbert548694
Blount546286
Autauga535862
Coffee460764
Dale409685
Franklin374150
Russell354215
Chilton344373
Covington338580
Escambia334544
Tallapoosa3143109
Dallas312996
Chambers303470
Clarke298036
Pike262431
Lawrence253355
Marion253161
Winston233342
Bibb222348
Geneva210247
Marengo208231
Pickens199531
Hale184944
Barbour180538
Fayette177829
Butler173160
Cherokee165131
Henry159525
Monroe152021
Randolph145536
Washington141727
Clay129746
Crenshaw123745
Macon121937
Cleburne121525
Lamar119922
Lowndes114836
Wilcox107922
Bullock103328
Perry99918
Conecuh97822
Sumter90527
Greene77923
Coosa63418
Choctaw51924
Out of AL00
Unassigned00
Tupelo
Cloudy
55° wxIcon
Hi: 57° Lo: 45°
Feels Like: 55°
Columbus
Cloudy
58° wxIcon
Hi: 60° Lo: 47°
Feels Like: 58°
Oxford
Cloudy
54° wxIcon
Hi: 55° Lo: 46°
Feels Like: 54°
Starkville
Cloudy
52° wxIcon
Hi: 57° Lo: 45°
Feels Like: 52°
WTVA Radar
WTVA Temperatures
WTVA Severe Weather